Milestone Pharmaceuticals Inc. MIST
0.79
(0.01)
(1.25%)
as of 25 Sep
- Market cap
- $99.0M
- P/E
- 0.0×
Follow MIST
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (35,522.62%) | (456.88%) | (229.65%) | (260.65%) |
+8 more TTM periods Free account |
|
| (73.36%) | (53.49%) | (66.71%) | (68.07%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(52.97%) | (39.79%) | (64.05%) | (76.05%) | |
Average Days of Receivables |
237.45 | 177.29 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.44) | (0.40) | (0.59) | (0.45) | |
Free Cash Flow |
(61.65) | (51.48) | (49.34) | (43.15) | |
Capital Expenditures |
(0.36) | (0.34) | (0.30) | (0.04) | |
Piotroski F-Score |
2.00 | 4.00 | — | — | |
| Other line items | |||||
Cash ROIC |
(24.71%) | (18.37%) | (23.93%) | (27.06%) | |
Accounts Receivable Turnover |
2.42 | 2.97 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.01 | 0.01 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | — | — | |
Average Days of Payables |
32,826.70 | 45,729.94 | 0.00 | 0.00 | |
Days of Inventory on Hand |
18,335.43 | 8,331.13 | 0.00 | — | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
306.23% | 262.60% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
579.89% | 271.42% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
140.12% | 118.50% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.73 | 0.75 | 0.78 | 0.74 | |
Depreciation/Fixed assets |
0.37 | 0.29 | 0.22 | 0.78 | |
Capex/Depreciation |
(2.07) | (2.38) | (2.65) | (0.39) | |
Revenue per Share |
0.04 | 0.05 | 0.00 | 0.00 | |
Operating CF per Share |
(0.44) | (0.39) | (0.58) | (0.45) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.07 | 0.05 | 0.00 | 0.00 | |
Net Profit Margin |
(1,586.01%) | (1,095.91%) | 0.00% | 0.00% |
Columns are period end dates